Table 1
|  | VL <500 c | VL ≥500 c | VL ≥500 nc |
|---|---|---|---|
PYFU | 3507 | 4274 | 934 |
Number of OIs | 104 | 414 | 223 |
Crude event rate (95% CI) | 3.0 (2.4–3.5) | 9.7 (8.8–10.6) | 23.9 (20.8–27.0) |
Adjusted rate ratio (95% CI) | 1.0 | 1.9 (1.5–2.4) | 4.3 (3.3–5.7) |
5 most commonly occurring OIs, n (% of all OIs): | Â | Â | Â |
Oesophageal candidiasis | 11 (11%) | 70 (17%) | 50 (22%) |
PCP | 6 (6%) | 11 (3%) | 21 (9%) |
Cytomegalovirus (CMV) chorioretinitis | 2 (2%) | 38 (9%) | 11 (5%) |
HIV wasting syndrome | 6 (6%) | 27 (7%) | 11 (5%) |
Mycobacterial tuberculosis, pulmonary | 6 (6%) | 22 (5%) | 13 (6%) |
Number of deaths | 86 | 104 | 259 |
Crude event rate (95% CI) | 2.5 (1.9–3.0) | 2.4 (2.0–2.9) | 27.7 (24.4–31.1) |
Adjusted rate ratio (95% CI) | 1.0 | 0.7 (0.5–1.0) | 8.5 (6.4–11.1) |
Median (IQR) | Â | Â | Â |
Calendar time of follow-up | 09/01 (06/99-06/04) | 04/00 (07/98-02/03) | 01/01 (03/99-08/03) |
CD4 count (/cells/mm3) | 148 (109–178) | 118 (61–160) | 108 (50–158) |
VL (log10 copies/mL) | 1.7 (1.7–2.3) | 4.4 (3.6–5.0) | 4.9 (4.3–5.4) |